胰腺癌新辅助化疗后的微创治疗

Minimally invasive treatment of pancreatic cancer following neo-adjuvant chemotherapy

根治性手术切除仍是唯一可能治愈胰腺癌的治疗方法。随着微创理念的更新,腹腔镜及机器人平台已被引入胰腺外科实践。目前的研究认为与标准开放方法相比,微创手术的围手术期的结果相似或有所改善。新辅助化疗越来越多地应用于胰腺外科,使手术切除更具挑战性。新辅助化疗后接受微创切除的患者数量仍然很低。笔者查阅国内外最新文献并阐述了胰腺癌新辅助化疗后的微创治疗现状。

Radical surgical resection is still the only potentially curative treatment for pancreatic cancer.With the update of minimally invasive concepts,the laparoscopic and robotic platform has been introduced to pancreatic surgery practice.The recent studies have demonstrated that minimally invasive procedure achieved similar or improved perioperative outcomes compared to the standard open approach.Neo-adjuvant chemotherapy is increasingly being applied in pancreatic surgery,making surgical resection more challenging.Numbers of patients undergoing minimally invasive resection following neo-adjuvant chemotherapy remain low.The author consulted the latest literatures at home and abroad and described the current situation of minimally invasive treatment of pancreatic cancer after neo-adjuvant chemotherapy.